Functional and joint evaluation in a prospective cohort of patients with severe haemophilia

Arthropathy is the main morbidity of haemophilia. Periodic joint health assessment enables a better understanding of the limitations of these patients.

[1]  K. Gilroy,et al.  5610611 REAL-WORLD EVIDENCE CHARACTERIZING THE BURDEN OF DISEASE IN ALPHA AND BETA THALASSEMIA PATIENTS IN THE USA: AN INTERIM ANALYSIS , 2023, HemaSphere.

[2]  G. Benson,et al.  Real-world utilities and health-related quality-of-life data in hemophilia patients in France and the United Kingdom , 2019, Patient preference and adherence.

[3]  D. Chaves,et al.  Prevalence and risk factors associated with hepatitis C among Brazilian male patients with haemophilia: A long‐term follow‐up , 2019, Haemophilia : the official journal of the World Federation of Hemophilia.

[4]  M. Kjelgaard‐Hansen,et al.  Bleed volume of experimental knee haemarthrosis correlates with the subsequent degree of haemophilic arthropathy , 2019, Haemophilia : the official journal of the World Federation of Hemophilia.

[5]  V. Blanchette,et al.  Measurement of joint health in persons with haemophilia: A systematic review of the measurement properties of haemophilia‐specific instruments , 2018, Haemophilia : the official journal of the World Federation of Hemophilia.

[6]  P. Wachholz,et al.  Challenges and perspectives in the treatment of patients with haemophilia in Brasil. , 2018, Revista da Associacao Medica Brasileira.

[7]  C. Kempton,et al.  A cross‐sectional study of non‐attendance among patients at a US hemophilia treatment center 2010‐2014 , 2018, Haemophilia : the official journal of the World Federation of Hemophilia.

[8]  R. Atun,et al.  The Brazilian health system at crossroads: progress, crisis and resilience , 2018, BMJ Global Health.

[9]  J. López-Pina,et al.  Effectiveness of the Medtep Hemophilia online platform for adherence to prophylactic treatment in haemophilia patients: Results from a 1‐year observational study , 2018, Haemophilia : the official journal of the World Federation of Hemophilia.

[10]  Xuan Zhou,et al.  [Prophylactic treatment with low- and intermediate-dose factor VIII in children with severe hemophilia A: comprehensive evaluation of joint outcomes and correlation analysis]. , 2018, Nan fang yi ke da xue xue bao = Journal of Southern Medical University.

[11]  I. Leite,et al.  Validation of the Brazilian version of the VERITAS-Pro scale to assess adherence to prophylactic regimens in hemophilia , 2017, Revista brasileira de hematologia e hemoterapia.

[12]  C. Peterfy,et al.  Effect of late prophylaxis in hemophilia on joint status: a randomized trial , 2017, Journal of thrombosis and haemostasis : JTH.

[13]  G. Auerswald,et al.  Intracranial haemorrhage in children and adolescents with severe haemophilia A or B – the impact of prophylactic treatment , 2017, British journal of haematology.

[14]  C. Thornburg,et al.  Treatment adherence in hemophilia , 2017, Patient preference and adherence.

[15]  S. Rezende,et al.  Evaluation of a web-based registry of inherited bleeding disorders: a descriptive study of the Brazilian experience with HEMOVIDAweb Coagulopatias , 2017, Orphanet Journal of Rare Diseases.

[16]  W. Miesbach,et al.  Adherence to prophylactic treatment in patients with haemophilia in Germany , 2016, Haemophilia : the official journal of the World Federation of Hemophilia.

[17]  E. Rodríguez‐Merchán,et al.  Objective quantification of adherence to prophylaxis in haemophilia patients aged 12 to 25years and its potential association with bleeding episodes. , 2016, Thrombosis research.

[18]  J. Oldenburg.  Optimal treatment strategies for hemophilia: achievements and limitations of current prophylactic regimens. , 2015, Blood.

[19]  Y. Oymak,et al.  The Effectiveness of Tools for Monitoring Hemophilic Arthropathy , 2015, Journal of pediatric hematology/oncology.

[20]  Y. Janu,et al.  Joint Health Status of Hemophilia Patients in Jodhpur Region , 2015, Indian Journal of Hematology and Blood Transfusion.

[21]  I. Leite,et al.  Hemophilia A in Brazil – epidemiology and treatment developments , 2014, Journal of blood medicine.

[22]  J. Sun,et al.  Chinese Hemophilia Joint Health Score 2.1 reliability study , 2014, Haemophilia : the official journal of the World Federation of Hemophilia.

[23]  K. Fischer,et al.  Using the Haemophilia Joint Health Score for assessment of teenagers and young adults: exploring reliability and validity , 2013, Haemophilia.

[24]  K. Khair,et al.  Factors affecting the Haemophilia Joint Health Score in children with severe haemophilia , 2013, Haemophilia : the official journal of the World Federation of Hemophilia.

[25]  J. Mahlangu,et al.  Guidelines for the management of hemophilia , 2013, Haemophilia : the official journal of the World Federation of Hemophilia.

[26]  I. Leite,et al.  Clinical and functional evaluation of the joint status of hemophiliac adults at a Brazilian blood center , 2013, Revista brasileira de hematologia e hemoterapia.

[27]  P. Paudyal,et al.  A systematic review of evidence for the effectiveness of practitioner-based complementary and alternative therapies in the management of rheumatic diseases: rheumatoid arthritis. , 2012, Rheumatology.

[28]  A. Shapiro,et al.  Modern haemophilia care , 2012, The Lancet.

[29]  L. Mantovani,et al.  A randomized clinical trial of prophylaxis in children with hemophilia A (the ESPRIT Study) , 2011, Journal of thrombosis and haemostasis : JTH.

[30]  J. Ingerslev,et al.  Utility of the Haemophilia Joint Health Score in study of episodically treated boys with severe haemophilia A and B in Lithuania , 2010, Haemophilia : the official journal of the World Federation of Hemophilia.

[31]  S. Rezende,et al.  Registry of inherited coagulopathies in Brazil: first report , 2009, Haemophilia : the official journal of the World Federation of Hemophilia.

[32]  F. Lafeber,et al.  Understanding haemophilic arthropathy: an exploration of current open issues , 2008, British journal of haematology.

[33]  A. Viswabandya,et al.  Psychometric analysis of the Functional Independence Score in Haemophilia (FISH) , 2007, Haemophilia : the official journal of the World Federation of Hemophilia.

[34]  Alan R. Cohen,et al.  Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia. , 2007, The New England journal of medicine.

[35]  B. Feldman,et al.  Hemophilia joint health score reliability study , 2006, Haemophilia : the official journal of the World Federation of Hemophilia.

[36]  C. Manigandan,et al.  Functional Independence Score in Haemophilia: a new performance‐based instrument to measure disability , 2005, Haemophilia : the official journal of the World Federation of Hemophilia.

[37]  L. Aledort,et al.  Can managed care support hemophilia in the 21st century? , 2005, American journal of hematology.

[38]  R. Doherty.  Long term follow up , 1999, BMJ.